Document Detail


Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with >1000 cases and review of the literature.
MedLine Citation:
PMID:  22467166     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the results of prenatal chromosomal microarray analysis (CMA) on >1000 fetal samples referred for testing at our institution and to compare these data to published reports.
METHODS: High resolution CMA was offered to women undergoing amniocentesis or chorionic villus sampling. Parental samples were obtained concurrently to exclude maternal cell contamination and assist interpretation of copy number variations.
RESULTS: Clinically significant copy number variations were observed in 85/1115 cases (7.6%) overall, and in 45/1075 cases (4.2 %) if 40 abnormal cases with known chromosome abnormalities or familial genomic imbalances were excluded. Eighteen of the 1115 cases had variants of unclear clinical significance (1.6%). Indications yielding the most clinically significant findings were abnormal karyotype/fluorescence in situ hybridization (26/61, 42.6%), family history of chromosomal abnormality (13/137, 9.5%), abnormal ultrasound (38/410, 9.3%), abnormal serum screening (2/37, 5.4%) and advanced maternal age (5/394, 1.3%). Of 1075 cases having no previously known cytogenetic abnormality or family history, 18 (1.7%) had clinically significant genomic changes undetectable by conventional prenatal chromosome analysis.
CONCLUSION: Current experience confirms that the detection rate of CMA for prenatal chromosomal abnormalities surpasses that of conventional karyotype analysis and continues to improve with higher resolution arrays, while maintaining a low frequency of results of unclear clinical significance. © 2012 John Wiley & Sons, Ltd.
Authors:
Amy Breman; Amber N Pursley; Patricia Hixson; Weimin Bi; Patricia Ward; Carlos A Bacino; Chad Shaw; James R Lupski; Arthur Beaudet; Ankita Patel; Sau W Cheung; Ignatia Van den Veyver
Related Documents :
273256 - Assignment of genes to regions of mouse chromosomes.
18200636 - Identification of deletion and duplication genotypes of the pmp22 gene using pcr-rflp, ...
11857566 - De novo interstitial direct duplication 1(q23.1q31.1) in a fetus with pierre robin sequ...
11453976 - Cryptic duplication of 21q in an individual with a clinical diagnosis of down syndrome.
19597486 - A two-step model for senescence triggered by a single critically short telomere.
20425326 - Lenalidomide (revlimid, cc-5013) in myelodysplastic syndromes: is it any good?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  32     ISSN:  1097-0223     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  351-61     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons, Ltd.
Affiliation:
Medical Genetics Laboratories, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Referral patterns for microarray testing in prenatal diagnosis.
Next Document:  Non-targeted whole genome 250K SNP array analysis as replacement for karyotyping in fetuses with str...